Reuters Events: Pharma Commercial Data and Tech 2026

Memo

We stand at a watershed moment. AI is no longer a roadmap item; it's a commercial imperative. Across Europe's pharma landscape, the organisations pulling ahead are those that have stopped experimenting and started executing turning fragmented data into intelligence engines, embedding AI into the workflows that drive revenue, and building the infrastructure that makes it all scale. The gap between those teams and everyone else is widening fast. And it won't wait. Reuters Events: Pharma Commercial Data and Tech 2026 is where Europe's most senior pharma commercial, data, and digital leaders come together to close that gap. With around 250 attendees, this is an exclusive, high-level gathering, not a trade show floor, but a room of peers who are navigating the same pressures, making the same bets, and willing to be honest about what's working and what isn't. Expect bold conversations on transforming CRM systems from glorified contact databases into dynamic commercial intelligence engines, ones that predict opportunities, surface real-time insights at the point of engagement, and serve as the execution layer for agentic AI. Expect a hard look at what precision customer engagement actually means when HCP and patient expectations are shifting beneath your feet, and AI is reshaping how health information is sought, trusted, and acted upon. Expect a frank discussion on the data infrastructure decisions being made right now that will determine who is AI-ready in 2027, and who is still untangling governance frameworks while competitors scale. And expect the conversation that every digital transformation leader in the room is quietly having: why do 85% of AI pilots never reach production, and what does it actually take to turn experiments into revenue engines? These aren't hypothetical challenges. They are sitting on the desks of every CDO, commercial director, and analytics leader in European pharma today, and the window to get ahead of them is narrowing. Explore how modern data architectures are reshaping enterprise capabilities - from privacy-preserving platforms and knowledge graphs to automation and LLM-ready infrastructure. Get practical on integrating GenAI safely, scaling analytics, and accelerating customer engagement from content to field enablement, all while meeting rigorous regulatory standards. Get on the front foot. Refocus. And walk away from Reuters Events: Pharma Commercial Data and Tech 2026 with the frameworks, partner relationships, and strategic clarity to deliver measurable commercial impact - not next year, but now. Tickets: https://go.evvnt.com/3619982-0?pid=5569 Date and Time: On Wed, 04 Nov 2026 08:00 - Thu, 05 Nov 2026 17:00 Venue Details: Hilton London Tower Bridge, 5 Tooley Street, London, England, SE1 2BY, United Kingdom Category: Conferences | Science, Health and Medicine | Pharmaceuticals Prices:Super early - End Users (rate expires 31/07/2026): GBP 699.00,Super early - Vendors (rate expires 31/07/2026): GBP 2799.00,Earlybird - End Users (rate expires 04/09/2026): GBP 849.00,Earlybird - Vendors (rate expires 04/09/2026): GBP 3099.00,Standard - End Users (rate expires 09/10/2026): GBP 999.00,Standard - Vendors (rate expires 09/10/2026): GBP 3399.00,Late - End Users (rate expires 05/11/2026): GBP 1199.00,Late - Vendors (rate expires 05/11/2026): GBP 3799.00